Inter Parfums Hits 20.5% Operating Margin: Beauty Benchmarks 2026

Executive summary. Across 9 public beauty brands totaling $27.9B in 2026 revenue, operating margin spans +20.5% (Inter Parfums) to -6.9% (Beauty Health) — a 27.4-point spread in one vertical. Fragrance licensing, retail platforms, and disciplined mass-prestige CPG all work. Salon-channel compression and sub-scale DTC destroy operating margin fast.

I run a finance team that has worked with three beauty brands directly — one $80M, one $20M, one mid-eight-figure — plus a fragrance brand and a hair-care company. Across every conversation with a private beauty operator at $5M-$50M, the same question shows up: what is the actual margin profile of the public brand I'm trying to model against? Most founders quote one number from a press release. That's not enough to decide where to invest.

This post pulls the financials of 9 public US beauty and personal care brands — all reporting in 2026 — and ranks them by operating margin. Then it splits them into the four operating models that actually exist in this industry: DTC challengers, retail platforms, salon-led specialty, and legacy CPG. Each model has its own gross-margin ceiling, its own S&M intensity, and its own death traps. If you are running a private beauty brand $5M-$50M, this is the benchmark map.

"With beauty, you can pull off 80, 85 gross margin. There's someone I know that's looking at a $100 million exit in beauty because the brand can be really sticky, and the margins are good, and so you have more money to market than anybody else does. Great business." — Matt Putra

The 9-company beauty benchmark table

Here is the full sample, sorted descending by operating margin. All figures pulled from public 10-K filings reporting fiscal 2026 results.

Rank	Brand	Category	Revenue	Op Margin	Gross Margin
1	Inter Parfums (IPAR)	Fragrance CPG	$1,317M	20.51%	71.88%
2	Ulta Beauty (ULTA)	Beauty retail	$12,393M	12.37%	39.10%
3	e.l.f. Beauty (ELF)	Beauty CPG	$1,314M	12.03%	71.24%
4	Sally Beauty (SBH)	Beauty retail (pro)	$3,701M	8.86%	51.62%
5	Edgewell (EPC)	Personal care CPG	$2,224M	4.34%	41.60%
6	Coty (COTY)	Beauty CPG	$5,893M	4.09%	64.84%
7	Olaplex (OLPX)	Salon haircare CPG	$423M	1.64%	69.43%
8	Honest Co (HNST)	Personal care DTC	$371M	-4.97%	33.33%
9	Beauty Health (SKIN)	Beauty device CPG	$301M	-6.92%	65.28%
Median (n=9)			$1,317M	4.34%	64.84%
Mean (n=9)			$3,104M	5.77%	56.48%

A few things worth pulling out from the table itself. The vertical median operating margin of 4.34% is barely above the cost of capital. Half the sample is below that. Three brands — Olaplex, Honest Co, Beauty Health — are at or below 1.6% operating margin despite gross margins of 33%-69%. Gross margin is the entry ticket, not the win condition.

How does the DTC challenger model perform?

The DTC challenger group in our sample is e.l.f. Beauty, Beauty Health, and Honest Co. The label is loose — e.l.f. is now mostly retail-distributed (Target, Walmart, Ulta), Beauty Health goes through both spa device channels and DTC, and Honest Co spans Amazon, Target, and DTC. What links them is that all three were built by founders trying to disrupt a category from the consumer-facing end rather than the wholesale shelf.

The results diverge sharply.

e.l.f. Beauty (ELF): the disciplined challenger

e.l.f. is the cleanest example of mass-prestige beauty done right. 71.2% gross margin, 21.4% S&M intensity, 59.2% SG&A intensity, 12.0% operating margin. The marketing machine is paid social + TikTok + influencer + retail-shelf velocity, and they spend 21 cents of every revenue dollar to feed it. That works only because gross margin is 71% — if it were 50%, the math would collapse.

The lesson for a private beauty operator: if you want to spend 20%+ of revenue on customer acquisition, your gross margin needs to be in the 65-75% zone, not 50%. e.l.f. is the proof that mass-channel beauty CPG can sustain DTC-level marketing intensity if the unit economics support it.

Beauty Health (SKIN): a cautionary tale

Beauty Health (HydraFacial parent) runs 65.3% gross margin — respectable beauty-device economics. The problem is S&M at 31.1% of revenue, the highest in the sample. Combined with a SG&A overhead structure built for a $400M+ revenue base that has compressed to $301M, operating margin landed at -6.9%.

This is the classic sub-scale CPG trap: the brand was sized for growth that didn't materialize, and now the cost structure is loss-making until either revenue rebases up or fixed cost gets cut hard. We see the private equivalent of this every quarter — brands that scaled to $40M, plateaued, and never re-cut overhead to match the new revenue level.

Honest Co (HNST): personal care DTC at sub-scale

Honest is the only brand in the sample running with 33.3% gross margin — the lowest by 8 points. Personal care has bulky, low-priced products, and the DTC plus mass retail channel mix forces a low gross margin. With S&M at 13.8% and SG&A at 21.4%, the operating margin is -5.0%. Less unit economics, fewer marketing dollars, and the brand still doesn't break even.

If your gross margin starts with a 3, you don't have a beauty business — you have a personal-care CPG, and you should benchmark against Edgewell (41.6% gross, 4.3% operating) or P&G, not against e.l.f.

The retail platform model: Ulta and Sally Beauty

Beauty retail is a different business than beauty CPG. The product margin is lower because retail rent eats it. The compensation is foot traffic, concession economics, and private label. Both Ulta and Sally clear 8.9%+ operating margin, but the underlying levers are very different.

Ulta Beauty (ULTA): the consumer beauty platform

Ulta runs $12.4B revenue at 12.4% operating margin. Gross margin is 39.1% — that's the spread after paying brand vendors and absorbing in-store labor. S&M is a remarkably tight 3.96%, because Ulta doesn't fund consumer demand for individual brands — the brands fund their own demand into the Ulta channel. SG&A at 26.6% covers the store fleet plus corporate.

The Ulta playbook: build a destination, monetize the destination via brand co-investment (vendor advertising, product placement, private label), and use Ulta Beauty Rewards as a first-party data engine. It's a media business as much as a retailer. For private beauty operators, the relevant lesson is that landing in Ulta is not just distribution — it's a media buy with sell-through obligations.

Sally Beauty (SBH): the professional channel

Sally runs $3.7B revenue at 8.9% operating margin with 51.6% gross margin — substantially higher than Ulta because Sally's mix is heavier on private label and on professional-only SKUs sold to stylists. S&M is the lowest in the sample at 1.78% — Sally doesn't compete for consumer awareness. The customer is the stylist, the channel is the shop, and the marketing is trade education.

What separates these two retail platforms: Ulta competes for consumer attention; Sally competes for stylist loyalty. Different cost structures, different growth ceilings, different terminal margin. Both viable, but you cannot copy both at once.

The salon and specialty channel: what happened at Olaplex?

Olaplex is the most instructive case study in the entire sample. From 2020 to 2022, this was a 25%+ operating-margin business with 70%+ gross margin and a moat built on patented bond-building technology distributed through salons. By fiscal 2026, operating margin was 1.64% on $423M revenue. Gross margin held at 69.4%. SG&A had bloated to 57.5% of revenue.

What broke wasn't the product or the gross margin. What broke was that the prestige hair-bond category compressed (K18, Living Proof, Redken added competing products), salon-led distribution lost some exclusivity to retail (Sephora, Ulta), and Olaplex didn't right-size SG&A as revenue declined. The result is a 1.6% operating margin business that, on paper, still looks like a beauty winner because gross margin is 69%.

The salon and specialty channel can produce industry-leading gross margin because of relationship-led distribution and clinical efficacy positioning. But it doesn't insulate operating margin if the brand premium erodes. For private salon-channel brands $5M-$50M, the lesson is that clinical and salon credibility build pricing power slowly — and lose it fast.

If you're operating a salon-channel brand right now, the Olaplex curve is your warning. The decision rubric is: when category competitors enter, do you cut overhead within 6 months, or do you sit at high SG&A through 18 months of revenue compression?

The legacy beauty CPG: Coty, Inter Parfums, Edgewell

The three legacy CPG operators in the sample sit at $1.3B, $2.2B, and $5.9B revenue. They each run a fundamentally different version of the beauty CPG model.

Inter Parfums (IPAR): fragrance licensing — the highest-margin beauty business

Inter Parfums is structurally the most profitable model in beauty: 20.5% operating margin on $1.32B revenue. Gross margin is 71.9%. S&M is just 4.1%. SG&A is 51.4%. The reason is that Inter Parfums licenses brand names from third parties (Jimmy Choo, Coach, Ferragamo, Lacoste, Karl Lagerfeld, Hollister) and the brand owners contribute brand equity. Inter Parfums runs the supply chain, distribution, and global wholesale; the brand owners fund the demand creation.

For a private operator, this is the exemplar of disciplined wholesale beauty. There is no version of operating with 20%+ margin if you spend 20%+ on S&M like e.l.f. does. The two roads to high operating margin in beauty are: (a) very low S&M with brand-owner-funded demand (Inter Parfums), or (b) high S&M offset by very high gross margin and disciplined SG&A (e.l.f.). Most private brands try to do neither and end up at 4-8% operating margin like Coty.

Coty (COTY): the mass-prestige conglomerate

Coty runs $5.9B revenue at 4.1% operating margin. The portfolio is mass-tier (CoverGirl, Rimmel, Max Factor) and prestige (Gucci Beauty, Burberry, Hugo Boss, Marc Jacobs). Gross margin is 64.8%, S&M is 26.7%, SG&A is 52.7%. The S&M intensity is comparable to e.l.f., but Coty has a more bloated SG&A structure because of the conglomerate footprint. The result is half the operating margin.

Coty is the best public example of "scale without leverage." More revenue, more marketing dollars, but the operating-leverage curve has flattened. Private operators looking at Coty as a benchmark should understand: $5.9B in beauty CPG can produce 4% operating margin. Scale alone does not earn you margin.

Edgewell (EPC): the personal care commodity

Edgewell (Schick, Wilkinson Sword, Banana Boat, Bulldog Skincare, Hawaiian Tropic) is the only true commodity personal care player in the sample. 41.6% gross margin, 5.7% S&M, 19.1% SG&A, 4.3% operating margin. The model is brutal — private label competition, retailer pricing power, low brand pricing power outside of premium niches. But the discipline is real: under 25% combined S&M plus SG&A, which is the lowest combined opex ratio in the sample.

If your private brand sells at $5-$15 retail and depends on grocery, drug, and mass distribution, your benchmark is Edgewell, not e.l.f. The economics are different and so should your expectations be.

What separates the winners from the losers?

Three variables drive the 27.4-point operating-margin spread across this 9-brand sample. Every private beauty brand decision needs to be evaluated against all three.

Variable 1: Gross margin (the entry ticket)

The 5 brands with operating margin above the 4.34% median all have gross margin between 39.1% and 71.9%. The 4 brands at or below 4.34% operating margin have gross margin between 33.3% and 69.4%. Gross margin is necessary but not sufficient — Olaplex has 69.4% gross and still landed at 1.6% operating. The lesson: high gross margin doesn't save you, but low gross margin (Honest's 33.3%) hard-caps your ceiling.

For a private $5M-$50M beauty brand, the gross-margin priorities are: hit 60%+ before scaling demand-gen spend, hit 70%+ before competing in mass-prestige, and hit 75%+ if you're salon or clinical-channel premium.

Variable 2: Marketing efficiency (the lever)

S&M as % of revenue spans 1.78% (Sally Beauty) to 31.1% (Beauty Health). The two extremes work or fail for different reasons. Low-S&M models (Inter Parfums 4.1%, Sally 1.78%, Ulta 4.0%) succeed because they don't compete for consumer demand — the demand is funded by brand owners or driven by foot traffic. High-S&M models (e.l.f. 21.4%, Coty 26.7%, Beauty Health 31.1%) only work when gross margin is 65%+ and the marketing is actually generating LTV-positive customers.

The death zone is 15-20% S&M with sub-60% gross margin. That's where Honest Co and roughly half the private brands we see operate. The model is simply unprofitable.

Variable 3: SG&A discipline (where margin dies quietly)

SG&A as % of revenue spans 19.1% (Edgewell) to 59.2% (e.l.f.). The high-SG&A brands (e.l.f., Olaplex, Coty, Inter Parfums) all carry an SG&A burden of 50%+ of revenue. e.l.f. and Inter Parfums make it work because gross margin is 71%+. Olaplex doesn't make it work because revenue compressed against fixed-cost SG&A.

For a private operator, SG&A is the place where margin dies quietly. People, software, real estate, audit, legal, and the slow accumulation of "we've always had this." Most beauty brands we work with at $20M-$50M have an SG&A line that's 5-10 percentage points larger than it needs to be, simply because nobody has audited it in 18 months.

Stage takeaways for private $5M-$50M beauty brands

Public benchmarks only matter if they help you make a decision. Here are the operating thresholds we work toward with private beauty brands at each stage.

$5M-$15M: prove the gross margin and contribution margin

• Gross margin target: 60%+ as a hard floor before scaling demand-gen spend.
• Contribution margin target: 25%+ after S&M and variable costs.
• S&M intensity at this stage will run 25-35% of revenue — that's normal for emerging DTC + Amazon + early retail. The math has to back it.
• SG&A target: under 30% of revenue. Founders will be wearing multiple hats; resist the urge to hire for prestige.
• Operating margin target: just don't lose money. Break-even or 5%+ EBITDA is the bar.

$15M-$30M: choose your model and double down

• Decide which lever you're pulling: high-S&M with high gross margin (e.l.f. model) or low-S&M with brand-owner funding or retail-led distribution (Inter Parfums or Ulta-vendor model).
• Gross margin target: 65%+ if pursuing high-S&M model. 55%+ if pursuing wholesale-heavy.
• S&M intensity: 20-25% if direct-to-consumer-led. 8-15% if retail-led.
• SG&A target: under 25% of revenue. The first finance leader, ops manager, and head of operations should arrive in this stage — but tightly.
• Operating margin target: 5-10% EBITDA.

$30M-$50M: capital efficiency or you'll get squeezed

• This is the stage where Beauty Health and Olaplex started missing. Sub-scale CPG with overbuilt overhead is the worst place to be.
• Gross margin target: 65-70%+ for any beauty brand, 50%+ for personal care.
• S&M intensity: should be coming down 1-2 points/year as brand awareness compounds. If it's flat at 25%+ for two consecutive years, you have a flywheel problem.
• SG&A target: under 25% of revenue with a clear path to 20% by $75M.
• Operating margin target: 10-15% EBITDA. Below that, M&A multiples compress meaningfully.

If you're a private operator above $50M and reading this, the public benchmark map is the same conversation: pick your model (DTC challenger, retail-led, salon-specialty, legacy CPG) and run the levers that make it work. Mid-points don't survive.

Frequently Asked Questions

Which public beauty brand has the highest operating margin in 2026?

Inter Parfums (NASDAQ: IPAR) leads the 9-company beauty and personal care sample with a 20.51% operating margin on $1.32B in revenue. The fragrance-licensing model — premium pricing, distributor distribution, low S&M intensity at 4.1% of revenue — is structurally the highest-margin business in beauty. e.l.f. Beauty is third at 12.03% on $1.31B, and Ulta Beauty second at 12.37% on $12.4B. The 27.4-point spread between Inter Parfums (+20.5%) and Beauty Health (-6.9%) at the bottom shows how widely operating economics diverge inside one vertical.

What is a healthy gross margin for beauty and personal care brands?

In our 9-company public beauty sample, the gross-margin median is 64.84% (Coty) and the interquartile range is 41.6% (Edgewell) to 69.4% (Olaplex). Beauty CPG with strong brand equity — Inter Parfums 71.9%, e.l.f. 71.2%, Olaplex 69.4% — sits in the 70% zone. Beauty retail platforms (Ulta 39.1%, Sally Beauty 51.6%) and personal care with mass distribution (Edgewell 41.6%, Honest Co 33.3%) sit lower because either retail rent dilutes margin or wholesale terms compress it. For private $5M-$50M brands, 60% gross margin is the entry ticket; 70%+ requires real brand equity.

Why do e.l.f. and Inter Parfums have such different margin profiles?

Both are profitable beauty CPGs at ~$1.3B revenue, but they get there differently. e.l.f. spends 21.4% of revenue on sales and marketing — the brand is paid social, TikTok, retail-shelf velocity, mass-prestige positioning. Inter Parfums spends 4.1% — the fragrance-licensing model uses brand-owner equity (Jimmy Choo, Coach, Ferragamo) plus distributor sell-through, so they don't need to fund consumer demand creation directly. Inter Parfums runs at 20.5% operating margin; e.l.f. at 12.0%. Both are healthy, but the structural levers are inverted. The lesson for private operators: pick which lever you compete on (efficiency or brand) — middle is the worst place to sit.

Is the beauty retail platform model still viable in 2026?

Yes, but only at scale. Ulta runs 12.4% operating margin on $12.4B revenue with 39.1% gross margin and tight S&M at 3.96% — the platform economics are sound because foot traffic + concession rent + private label + Sephora-style discovery monetization still works. Sally Beauty runs 8.9% operating margin on $3.7B with 51.6% gross margin (private label heavier mix), but only 1.78% S&M because Sally is professional/stylist-led and doesn't compete for awareness the way Ulta does. The model is viable; the warning is that retail platforms below $1B revenue rarely scale to these margins because store-level fixed costs swallow the math.

What does the salon and specialty channel margin profile look like?

Olaplex is the cleanest public read on the salon-led specialty model: 69.4% gross margin (premium pricing, IP-protected formulas), but only 1.64% operating margin because SG&A runs at 57.5% of revenue. Olaplex went from a 25%+ operating-margin business in 2022 to 1.6% as the prestige hair-bond category compressed and competing salon-distribution brands eroded share. The salon channel can produce industry-leading gross margin because of relationship-led distribution and clinical efficacy positioning, but it doesn't insulate operating margin if the brand premium erodes. For private salon-channel brands $5M-$50M, the lesson is that clinical and salon credibility build pricing power slowly and lose it fast.

Sources

• Eightx Operating Margin by DTC Vertical (2026) — cross-vertical comparison set, 45 public brand sample.
• Eightx Why e.l.f. Beauty Outperforms (2026) — deep-dive on the e.l.f. operating model.
• Eightx Olaplex Haircare Margin Machine (2026) — Olaplex compression case study.
• Inter Parfums Inc. (NASDAQ: IPAR) Form 10-K, fiscal 2026.
• Ulta Beauty Inc. (NASDAQ: ULTA) Form 10-K, fiscal 2026.
• e.l.f. Beauty Inc. (NYSE: ELF) Form 10-K, fiscal 2026.
• Sally Beauty Holdings Inc. (NYSE: SBH) Form 10-K, fiscal 2026.
• Edgewell Personal Care Co. (NYSE: EPC) Form 10-K, fiscal 2026.
• Coty Inc. (NYSE: COTY) Form 10-K, fiscal 2026.
• Olaplex Holdings Inc. (NASDAQ: OLPX) Form 10-K, fiscal 2026.
• The Honest Company Inc. (NASDAQ: HNST) Form 10-K, fiscal 2026.
• The Beauty Health Company (NASDAQ: SKIN) Form 10-K, fiscal 2026.